Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COCOS trial amendment for persistent smell loss after COVID-19
NL-OMON54199Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Olfactory disorder, anosmia and Gustatory Dysfunction comparing Prednisolone with Placebo (2 arms). Primary endpoint: Objective olfactory function. Started Nov 2021; status: completed.
02
Drugs
prednisolone
03
Conditions
Olfactory disorderanosmiaGustatory Dysfunction
Beyond the preview
Go deeper on NL-OMON54199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54199.